
Concentration
10 mg
evé · PT-141 · 10mg vialPT-141 (Bremelanotide) is a synthetic melanocortin-receptor agonist derived from Melanotan II. Research has explored its central effects on sexual arousal pathways. For research use only.
A summary of the published research. We make compounds — we don't make claims.
Retatrutide is Eli Lilly's LY3437943. A 39-residue peptide, built one amino acid at a time on a solid support. Where tirzepatide pulls on two incretin pathways, retatrutide pulls on three. The third one — glucagon — is what makes the molecule interesting. It is also what makes it incomplete: phase 3 readouts are still pending at the time of writing.
Drawn from preclinical and clinical research literature. Provided as reference, not as therapeutic guidance. We do not characterise outcomes in humans.
Portland, ME · DEA-licensedWe build the peptide on a resin, one Fmoc-protected residue at a time — thirty-nine couplings, then cleavage. The crude is purified twice on reverse-phase HPLC against a reference standard. Identity confirmed by ESI mass spectrometry. Numbers logged at every step.
What comes out is a white cake in a sealed glass vial. Argon-purged, tamper-banded, labelled with the lot number you'll find on the bottle in your hand.
Every lot has a record. Eleven days, four hands, one vial — this is the ledger for the one in your box.